Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell, Peripheral × Brentuximab Vedotin × Clear all

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Triple Negative Breast Neoplasms

NCT03302728 2022-05-19

EpiBrentlen

Phase 1 Completed

6 enrolled

DermatologicLymphoid

Hodgkin Disease, Recurrence, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Clinical Trials

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

EpiBrentlen